Process Development toward a Key Fragment of the PCSK9 Inhibitor Enlicitide Decanoate

已完结 10 由小太阳发布于 2026/7/20 10:05:53

DOI:10.1021/acs.oprd.4c00504
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1021/acs.oprd.4c00504

American Chemical Society (ACS)

Abstract：Here we report the development of a large-scale manufacturing process for the synthesis of the Northern Fragment of enlicitide decanoate (MK-0616), an orally bioavailable inhibitor of propro

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierAssessment of water supply–demand matching under intensive human activities from the perspective of ecosystem service synergies and trade-offs: A case study in the Haihe River Basin of China